Active surveillance is not doing nothing. It is structured monitoring for selected prostate cancers.
Active surveillance can be appropriate for selected men with lower-risk prostate cancer. The decision should be made with a urologist who can explain risk category, PSA pattern, MRI, biopsy grade, repeat testing, triggers for treatment, and the tradeoffs of surgery or radiation if the cancer changes.
Active surveillance is for selected lower-risk prostate cancers, not every prostate cancer.
Monitoring can include PSA, exam, MRI, repeat biopsy, and risk reassessment.
Treatment becomes appropriate if risk changes or the patient chooses definitive care after informed discussion.
Searches this guide answers
Built to beat broad cancer-center pages locally
Large cancer centers own broad information. This page aims at the local decision search: should I watch this prostate cancer or treat it, and who should guide me in New Jersey?
Local decision path
It connects active surveillance to an Edison/NJ urologic oncology consult instead of only national education.
Full pathway
It covers MRI, repeat biopsy, pathology, surgery, and radiation handoff questions.
No undertreatment claim
It makes clear that surveillance is only for selected risk profiles and must be followed.
Before choosing surveillance
- Grade group and biopsy details
- PSA trend and PSA density
- MRI findings
- Number of positive cores and cancer volume
- Comfort with repeat testing and treatment triggers
What changes active surveillance candidacy?
Cancer risk group
Grade group, PSA, stage, and biopsy volume shape whether surveillance is reasonable.
MRI and biopsy quality
Good initial staging reduces the chance of missing higher-risk disease.
Patient age and health
Life expectancy and other conditions change the balance of monitoring vs treatment.
Follow-up reliability
Surveillance only works if the patient completes PSA, MRI, biopsy, and visit follow-up.
Treatment triggers
Patients should know what changes would lead to surgery, radiation, or another plan.
What active surveillance means
Active surveillance means watching selected prostate cancer closely and delaying treatment unless risk changes. It is different from ignoring cancer.
The plan usually includes periodic PSA testing, exams when indicated, MRI, repeat biopsy in selected intervals, and reassessment of grade or volume changes.
Who may be a candidate
Men with low-risk disease, limited cancer volume, favorable MRI findings, and reliable follow-up may be candidates. Some favorable intermediate-risk patients may also discuss surveillance, but selection becomes more nuanced.
The decision depends on pathology, PSA density, MRI, age, health, family history, and how the patient weighs treatment side effects against cancer risk.
When treatment enters the conversation
Treatment may be discussed if grade group increases, cancer volume grows, MRI becomes more concerning, PSA pattern changes, or the patient decides the monitoring burden is not acceptable.
Innovative Urology can compare active surveillance, robotic prostatectomy, radiation, focal therapy questions, and continued monitoring without pretending one path fits every patient.
Monitoring vs treatment decisions
Active surveillance
Selected lower-risk prostate cancer with reliable follow-up.
Costs are tied to monitoring visits, PSA, MRI, and repeat biopsy.
Robotic prostatectomy
Selected patients where surgery is appropriate based on risk and goals.
Estimate hospital, anesthesia, pathology, catheter, and follow-up.
Radiation therapy
Patients where radiation is preferred or surgery is not the best fit.
Radiation oncology billing and treatment duration differ from surgery.
Watchful waiting
Older or medically fragile patients where symptom control may matter more than curative treatment.
Different intent from active surveillance.
Next step for New Jersey patients
Request a consultation if these questions match your symptoms, diagnosis, or treatment decision. Innovative Urology serves patients from Westfield, Summit, Short Hills, Millburn, Livingston, Edison, Woodbridge, Morristown, and nearby New Jersey communities.
Continue your decision path
Related treatment, comparison, local, and patient pages.
Prostate cancer
View page
Prostate MRI
View page
Robotic prostatectomy
View page
Prostatectomy and hernia repair
View page
Prostate MRI vs biopsy
View page
Prostate cancer surgeon in NJ
View page
Prostate cancer second opinion
View page
Treatments
Procedure pages for decision-stage patients.
View page
Comparisons
Compare treatment and diagnostic options.
View page
Patient information
Appointments, insurance, second opinions, and forms.
View page
Active surveillance questions
Is active surveillance safe?
It can be safe for selected lower-risk prostate cancer when follow-up is structured and completed. It is not appropriate for every patient.
Does Gleason 6 always need treatment?
Many Gleason 6 prostate cancers can be monitored, but candidacy depends on PSA, MRI, biopsy volume, age, health, and patient preference.
When do patients leave active surveillance?
Treatment may be recommended if grade, volume, MRI findings, PSA pattern, or patient preference changes.
Sources